evid specif effect serum patient cystic fibrosi sodiumdepend glucos transport rat jejunum sera patient cystic fibrosi pancrea cf normal human sera assay abil inhibit sodium depend glucos transport rat brushbord membran vesicl fresh cf age sexmatch control sera inhibitori compar physiolog salin inhibit cf serum wa 44 13 mean sd final serum concentr 67 67 34 10 serum 68 28 20 serum ratio inhibit cf sera compar control sera wa 100 078 093 67 10 20 serum concentr respect although slightli greater inhibit cf serum wa observ concentr 10 thi probabl signific becaus differ could detect concentr 20 serum glucos transport presenc serum wa sensit phlorizin indic residu glucos transport wa proceed sodiumdepend glucos transport system find suggest cf serum doe specif inhibit sodiumdepend glucos transport system intravesicular space access glucos wa reduc presenc cf control serum fresh cf serum wa 14 time effect fresh control serum p less 001 presenc substanti vesicl shrink activ control serum indic thi activ cannot consid specif cf